We are dedicated to acquiring and providing strategic resources and expansion capital to innovative healthcare companies that strive to provide much needed healthcare and related products to patients in need. By partnering with exceptional entrepreneurs we aim to help to create market-leading products in the biomedical and healthcare sector. As entrepreneurs and investors with operational and technical expertise we embrace a collaborative approach to capital formation and business development.
See and hear How we Tell Our Corporate Story
ABOUT QBIO by OUR CEO
QUARTERLY & ANNUAL REPORTS
PRESS AND NEWS
Q Biomed Inc. to Present at the Microcap Conference Taking Place April 9-10 at the Essex House in New York City
NEW YORK, April 5, 2018 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration company, announced today that Denis Corin, Chief Executive Officer, will present at the MicroCap Conference being held at the Essex House in New York...
Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Strontium Chloride SR89 Injection USP for Relief of Cancer Bone Pain
NEW YORK, March 16, 2018 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, and Bio-Nucleonics, licensor of Strontium 89 Chloride, announce submission of a regulatory filing to the FDA for the approval of a...
Q BioMed Inc. to Present at 30th Annual Roth Conference, Taking Place March 11-14, 2018, in Dana Point, CA
NEW YORK, March 9, 2018 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration company, announced today that Denis Corin, Chief Executive Officer will present at the 30th Annual Roth Conference, being held at the Ritz Carlton in Dana...
SEE OUR REPORTS AND FILINGS
Copyright © 2018 Q BioMed, Inc. All Rights Reserved
501 Madison Ave, 14th Floor
New York, NY 10022 USA
P: +1 888 357 2435